老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Bioxcel Therapeutics Inc.

3.75
+0.17004.75%
成交量：300.95万
成交额：1,130.81万
市值：5,458.76万
市盈率：-0.31
高：3.95
开：3.60
低：3.51
收：3.58
52周最高：13.36
52周最低：1.17
股本：1,455.67万
流通股本：551.26万
量比：1.82
换手率：54.59%
股息：- -
股息率：- -
每股收益(TTM):-12.2842
每股收益(LYR):-23.5105
净资产收益率：-1766.94%
总资产收益率：-68.72%
市净率：-0.51
市盈率(LYR):-0.16

数据加载中...

总览公司新闻公告
2020/07/27

重要事件披露

8-K - Current report
2020/06/24

重要事件披露

8-K - Current report
2020/05/21

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/05/21

重要事件披露

8-K - Current report
2020/05/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/12

重要事件披露

8-K - Current report
2020/04/15

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2020/03/09

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/09

重要事件披露

Current report, items 2.02 and 9.01
2020/03/06

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/24

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/21

重要事件披露

Current report, items 1.01 and 9.01
2020/02/19

重要事件披露

Current report, items 2.02 and 8.01
2020/02/18

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, item 7.01
2019/11/26

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/11/14

重要事件披露

Current report, items 2.02 and 9.01
2019/11/14

季度报告

Quarterly report [Sections 13 or 15(d)]
更多